Company Beijing Luzhu Biotechnology Co., Ltd.

2480

CNE100005YD8

Pharmaceuticals

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Biopharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:24 08/07/2024 pm IST			5-day change	1st Jan Change
22.8 ^HKD	+2.47%		+3.87%	-23.75%

07/05	59,729,296 Domestic Shares of Beijing Luzhu Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	CI
07/05	132,333,736 H Shares of Beijing Luzhu Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	CI

Beijing Luzhu Biotechnology Co Ltd is a China-based company principally engaged in drug discovery, research and development and commercialization. The Company is also engaged in out-licensing human vaccines and therapeutic biologics. Its products under clinical development include recombinant herpes zoster vaccine LZ901, and antibody injection products K3 and K193. Its LZ901 is mainly used to prevent herpes zoster caused by varicella zoster virus in adults aged 50 and above. The Company operates in the domestic market and overseas markets.

Number of employees: 133

Managers	Title	Age	Since
Jian Kong CEO	Chief Executive Officer	61	01/02/01
Hui Zhang DFI	Director of Finance/CFO	56	-
Ling Peng CHM	Chairman	43	11/18/11
Xian Min Jiang CTO	Chief Tech/Sci/R&D Officer	61	19/13/19
Yan Ping Zhang BRD	Director/Board Member	-	28/13/28
Ho Yan Lai SEC	Corporate Secretary	-	18/22/18
Si Yu Liu SEC	Corporate Secretary	33	01/21/01

Members of the board	Title	Age	Since
Biao Ma BRD	Director/Board Member	60	26/19/26
Ai Jun Hou BRD	Director/Board Member	58	-
Yan Ping Zhang BRD	Director/Board Member	-	28/13/28
Jian Kong CEO	Chief Executive Officer	61	01/02/01
Xian Min Jiang CTO	Chief Tech/Sci/R&D Officer	61	19/13/19
Shuang Quan Kong BRD	Director/Board Member	50	26/19/26
Ling Peng CHM	Chairman	43	11/18/11
Ye Shi Liang BRD	Director/Board Member	74	-
Xi Kong BRD	Director/Board Member	31	21/14/21
Li Ang Chen BRD	Director/Board Member	44	26/22/26

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	59,729,296	0	0	8.669 %
Stock B	1	142,719,736	17,550,933 ( 12.30 %)	0

Name	Equities	%	Valuation
Beijing E Town Sun Fund Management Co ltd 18.76 %	37,969,696	18.76 %	107 M $
Yan Ping Zhang 9.978 %	20,200,000	9.978 %	57 M $
BEIJING SCIENCE SUN PHARMACEUTICAL CO., LTD. 6.793 %	13,751,500	6.793 %	39 M $
Zhuhai Hengqin Luzhu Enterprise Management Partnership LP 6.079 %	12,307,500	6.079 %	35 M $
CCB International (China) Co., Ltd. 5.761 %	11,664,075	5.761 %	33 M $
Herui Venture Capital Fund Management (Shenzhen) Co. Ltd. 4.940 %	10,000,744	4.940 %	28 M $
Jinjiang Zhenrui Equity Investment Aprtnership LP 3.841 %	7,776,050	3.841 %	22 M $
Xian Min Jiang 1.976 %	4,000,000	1.976 %	11 M $
Xi Kong 0.2717 %	550,000	0.2717 %	2 M $

Name	Equities	%	Valuation
Jian Kong 28.79 %	58,294,513	28.79 %	164 M $

Beijing Lüzhu Biotechnology Co., Ltd.

3 Guangtong Street Industrial Development Zone

101113, Beijing

http://www.luzhubiotech.com

address Beijing Luzhu Biotechnology Co., Ltd.(2480)

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

21.22 CNY

Average target price

27.73 CNY

Spread / Average Target

+30.68%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
BEIJING LUZHU BIOTECHNOLOGY CO., LTD.	-23.75%	577M
CSL LIMITED	+3.11%	97.7B
SAMSUNG BIOLOGICS CO.,LTD.	+4.21%	41.43B
BIOGEN INC.	-11.86%	32.85B
UCB	+80.99%	29.33B
BIOMARIN PHARMACEUTICAL INC.	-14.25%	15.47B
INCYTE CORPORATION	-7.36%	12.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-13.08%	11.51B
ALTEOGEN INC.	+176.65%	10.74B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-57.36%	8.97B

Biopharmaceuticals